Journal of Hepatology
Volume 28, Issue 5 , Pages 778-784 , May 1998

Plasma levels of soluble tumor necrosis factor receptors p55 and p75 in patients with alcoholic liver disease of increasing severity

  • Sylvie Naveau

      Affiliations

    • Corresponding Author InformationCorrespondence: Sylvie Naveau, Service d'Hépato-Gastro-Entérologie, Hôpital Antoine Béclère, 157 rue de la Porte de Trivaux, 92141 Clamart Cedex, France Tel: 01.45.37.43.69. Fax: 01.40.94.06.56.
    • Service d'Hépato-Gastro-Entérologie, Hôpital A. Béclère, Clamart, France
    • ,
  • Dominique Emilie

      Affiliations

    • INSERM U131, Institut Paris-Sud sur les Cytokines, Clamart, France
    • ,
  • Axel Balian

      Affiliations

    • Service d'Hépato-Gastro-Entérologie, Hôpital A. Béclère, Clamart, France
    • INSERM U131, Institut Paris-Sud sur les Cytokines, Clamart, France
    • ,
  • Liliane Grangeot-Keros

      Affiliations

    • INSERM U131, Institut Paris-Sud sur les Cytokines, Clamart, France
    • Service de Bactériologie-Immunologie, Hôpital A. Béclère, Clamart, France
    • ,
  • Eric Borotto

      Affiliations

    • Service d'Hépato-Gastro-Entérologie, Hôpital A. Béclère, Clamart, France
    • ,
  • Alain Portier

      Affiliations

    • INSERM U131, Institut Paris-Sud sur les Cytokines, Clamart, France
    • ,
  • Vincent Giraud

      Affiliations

    • Service d'Hépato-Gastro-Entérologie, Hôpital A. Béclère, Clamart, France
    • ,
  • Frédérique Capron

      Affiliations

    • Service d'Anatomie Pathologique, Hôpital Antoine Béclère, Clamart, France
    • ,
  • Pierre Galanaud

      Affiliations

    • INSERM U131, Institut Paris-Sud sur les Cytokines, Clamart, France
    • ,
  • Jean-Claude Chaput

      Affiliations

    • Service d'Hépato-Gastro-Entérologie, Hôpital A. Béclère, Clamart, France

Received 5 July 1997 ,Revised 9 December 1997 ,Accepted 22 December 1997.

References 

  1. Symposium: oxidative stress in alcoholic liver injury Alcohol Clin Exp Res. 1996;20:162–167
  2. Le J, Vilcek J. Biology of disease. Tumor necrosis factor and interleukin-1: cytokines with multiple overlapping biological activities. Lab Invest. 1987;56:234–248
  3. Vilcek J, Lee TH. Tumour necrosis factor. New insights into the molecular mechanisms of its multiple actions. J Biol Chem. 1991;266:7313–7316
  4. Khoruts A, Stahnke L, MacClain CJ, Logan G, Alen JL. Circulating tumor necrosis factor, interleukin-1 and interleukin-6 concentrations in chronic alcoholic patients. Hepatology. 1991;13:267–276
  5. Rodriguez-Rodriguez E, Gonzalez-Reimers É, Santolaria-Fernandez F, Milena-Abril A, Rodriguez-Moreno F, Oramas-Rodriguez J, et al.  Cytokine levels in acute alcoholic hepatitis: a sequential study. Drug Alcohol Depend. 1995;39:23–27
  6. Bird GLA, Sheron N, Goka J, Alexander GJ, Williams RS. Increased plasma tumor necrosis factor in severe alcoholic hepatitis. Ann Intern Med. 1990;112:917–920
  7. MacClain CJ, Cohen DA. Increased tumor necrosis factor production by monocytes in alcoholic hepatitis. Hepatology. 1989;9:349–351
  8. Volpes R, Van Den Cord JJ, De Voo R, Desmet VJ. Hepatic expression of type A and type B receptors for tumor necrosis factor. J Hepatol. 1992;14:361–369
  9. Tartaglia LA, Goeddel DV. Two TNF receptors. Immunol Today. 1992;13:151–153
  10. Tartaglia LA, Weber RF, Figari IS, Reynolds C, Palladino MA, Goeddel DV. The two different receptors for tumor necrosis factor mediate distinct cellular responses. Proc Natl Acad Sci USA. 1991;88:9292–9296
  11. Nophar Y, Kemper O, Brakebusch C, Engelmann H, Zwang R, Aderka D, et al.  Soluble forms of tumor necrosis factor receptors (TNF-Rs). The CDNA for the type I TNF-R, cloned using amino acid sequence data of its soluble form, encodes both the cell surface and a soluble form of the receptor. EMBO J. 1990;9:3269–3278
  12. Diez-Ruiz A, Tilz GP, Gutierrez-Gea F, Gil-Extremera B, Murr C, Wachter H, et al.  Neopterin and soluble tumor necrosis factor receptor type I in alcoholic-induced cirrhosis. Hepatology. 1995;21:976–978
  13. Review by an International Group. Alcoholic liver disease. Morphological manifestations. Lancet. 1981;i:707–711
  14. Carithers RL, Herlong HF, Diehl AM. Methyl prednisolone therapy in patients with severe alcoholic hepatitis: a randomized multicenter trial. Ann Intern Med. 1989;110:685–690
  15. Seckinger P, Isaaz S, Dayer JM. A human inhibitor of tumor necrosis factor α. J Exp Med. 1988;167:1511–1516
  16. Tilg H, Vogel W, Wiedermann CJ, Shapiro L, Herold M, Judmaier G, et al.  Circulating interleukin 1 and tumor necrosis factor antagonists in liver disease. Hepatology. 1993;18:1132–1138
  17. Marinos G, Naoumov NV, Rossol S, Torre F, Wong PYN, Gallati H, et al.  Tumor necrosis factor receptors in patients with chronic hepatitis B virus infection. Gastroenterology. 1995;108:1453–1463
  18. Feluer ME, Mezey E, MacGuire M, Mitchell MC, Herlong HF, Veech GA, et al.  Plasma tumor necrosis factor α predicts decreased long-term survival in severe alcoholic hepatitis. Alcohol Clin Exp Res. 1990;14:255–259
  19. Wang JH, Redmond HP, Watson RWG, Bouchier Hayes D. Role of lipopolysaccharide and tumor necrosis factor α, in induction of hepatocyte necrosis. Am J Physiol. 1995;269:G297–G304
  20. Adamson GM, Billings RE. Tumor necrosis factor-induced oxidative stress in isolated mouse hepatocytes. Arch Biochem Biophys. 1992;294:223–229
  21. Leist M, Gantner F, Jilg S, Wendel A. Activation of the 55 KDa TNF receptor is necessary and sufficient for TNF-induced liver failure, hepatocyte apoptosis and nitrite release. J Immunol. 1995;154:1307–1316
  22. Bertoletti A, Ferrari C, Fiaccadori F, Penna A, Margolskee R, Schlicht HV, et al.  HLA class I restricted human cytotoxic T cells recognize endogenously synthesized hepatitis B virus nucleocapsid antigen. Proc Natl Acad Sci USA. 1991;88:10 445–10 449
  23. Koziel MJ, Dudley D, Wong JT, Dienstag J, Houghton M, Ralston R, et al.  Intrahepatic cytotoxic T lymphocytes specific for hepatitis C virus in persons with chronic hepatitis. J Virol. 1992;149:3339–3344
  24. Kallinowski B, Haseroth K, Muller M, Stremmel W, Singer MV, Rossol S. Induction of TNF receptor type p55 and p75 in patients with chronic hepatitis C virus (HCV) infection: in vivo and in vitro [abstract]. Hepatology. 1997;26:1118; (Pt 2)

PII: S0168-8278(98)80227-4

Journal of Hepatology
Volume 28, Issue 5 , Pages 778-784 , May 1998

Article Tools